Taro Pharmaceuticals, the Israel -based subsidiary of Sun Pharmaceuticals, has voluntarily recalled 39,982 tubes of Fluorouracil Topical Cream USP, used to treat various skin conditions, from the US and Puerto Rico markets. The company has recalled the same as its product lacks stability.
As per the USFDA, class II recalls are done in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Sun Pharma had acquired a controlling stake in Taro in September, 2010. The Mumbai-based firm currently holds 66.5 per cent stake in Taro.
